Search Results Search Sort by RelevanceMost Recent Policy Forum Mar 2005 Health Care for Incarcerated Adolescents: Significant Needs with Considerable Obstacles Robert E. Morris, MD Virtual Mentor. 2005;7(3):244-248. doi: 10.1001/virtualmentor.2005.7.3.pfor2-0503. Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 1 Patrick D. Guinan, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 2 Malika Haque, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505. Case and Commentary May 2005 End of Life and Sanctity of Life, Commentary 3 Lerwut Wongsarnpigoon, MD Virtual Mentor. 2005;7(5):342-351. doi: 10.1001/virtualmentor.2005.7.5.ccas2-0505. Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 1 Marion Danis, MD Virtual Mentor. 2004;6(1):6-8. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401. Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 2 Leonard M. Fleck, PhD Virtual Mentor. 2004;6(1):9-11. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401. Viewpoint Dec 2001 Doctors in Black and White on the Big and Small Screens Kayhan Parsi, JD, PhD Virtual Mentor. 2001;3(12):446-448. doi: 10.1001/virtualmentor.2001.3.12.ebyt1-0112. Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Policy Forum Mar 2005 Health Care for Incarcerated Adolescents: Significant Needs with Considerable Obstacles Robert E. Morris, MD Virtual Mentor. 2005;7(3):244-248. doi: 10.1001/virtualmentor.2005.7.3.pfor2-0503.
Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 1 Patrick D. Guinan, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 2 Malika Haque, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505.
Case and Commentary May 2005 End of Life and Sanctity of Life, Commentary 3 Lerwut Wongsarnpigoon, MD Virtual Mentor. 2005;7(5):342-351. doi: 10.1001/virtualmentor.2005.7.5.ccas2-0505.
Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 1 Marion Danis, MD Virtual Mentor. 2004;6(1):6-8. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401.
Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 2 Leonard M. Fleck, PhD Virtual Mentor. 2004;6(1):9-11. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401.
Viewpoint Dec 2001 Doctors in Black and White on the Big and Small Screens Kayhan Parsi, JD, PhD Virtual Mentor. 2001;3(12):446-448. doi: 10.1001/virtualmentor.2001.3.12.ebyt1-0112.
Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404.